Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 21-May-20 4:31 PM View:  | Phillips Gary M Director | Zyla Life Sciences (ZCOR) | 20-May-20 | Disposition | 33,620 | -- | -- | (100%) 33.62K to 0 | |
| 21-May-20 4:31 PM View: | Smith Todd N President and CEO Director | Zyla Life Sciences (ZCOR) | 20-May-20 | Disposition | 365,500 | -- | -- | (100%) 365.5K to 0 | |
| 21-May-20 4:30 PM View: | Timmins Megan C. General Counsel | Zyla Life Sciences (ZCOR) | 20-May-20 | Disposition | 107,951 | -- | -- | (100%) 107.95K to 0 | |
| 21-May-20 4:32 PM View: | Walbert Timothy P Director | Zyla Life Sciences (ZCOR) | 20-May-20 | Disposition | 26,953 | -- | -- | (100%) 26.95K to 0 | |
| 21-May-20 4:33 PM View: | Strobeck Mark Chief Operating Officer | Zyla Life Sciences (ZCOR) | 20-May-20 | Disposition | 180,864 | -- | -- | (100%) 180.86K to 0 | |
| 21-May-20 4:33 PM View: | McInnis Joe Director | Zyla Life Sciences (ZCOR) | 20-May-20 | Disposition | 26,953 | -- | -- | (100%) 26.95K to 0 | |
| 22-May-20 4:07 PM View: | Capital Royalty L.P. 10% Owner | Zyla Life Sciences (ZCOR) | 20-May-20 | Disposition | 4,586,870 | -- | -- | (100%) 4.59M to 0 | |
| 21-May-20 4:32 PM View: | Smiley Andrea Heslin Director | Zyla Life Sciences (ZCOR) | 20-May-20 | Disposition | 26,953 | -- | -- | (100%) 26.95K to 0 | |
| 21-May-20 4:31 PM View: | Pauls Matthew Director | Zyla Life Sciences (ZCOR) | 20-May-20 | Disposition | 26,953 | -- | -- | (100%) 26.95K to 0 | |
| 24-Apr-20 6:13 PM View: | Smiley Andrea Heslin Director | Zyla Life Sciences (ZCOR) | 23-Apr-20 | Option Exercise | 6,667 | $1.75 | $11,667.20 | 100% 0 to 6.67K | |
| 24-Apr-20 6:12 PM View: | Pauls Matthew Director | Zyla Life Sciences (ZCOR) | 23-Apr-20 | Option Exercise | 6,667 | $1.75 | $11,667.20 | 100% 0 to 6.67K | |
| 24-Apr-20 6:13 PM View: | Walbert Timothy P Director | Zyla Life Sciences (ZCOR) | 23-Apr-20 | Payment of Exercise | 952 | $1.75 | $1,666.00 | (14%) 6.67K to 5.71K | |
| 24-Apr-20 6:11 PM View: | McInnis Joe Director | Zyla Life Sciences (ZCOR) | 23-Apr-20 | Payment of Exercise | 952 | $1.75 | $1,666.00 | (14%) 6.67K to 5.71K | |
| 24-Apr-20 6:13 PM View: | Smiley Andrea Heslin Director | Zyla Life Sciences (ZCOR) | 23-Apr-20 | Payment of Exercise | 952 | $1.75 | $1,666.00 | (14%) 6.67K to 5.71K | |
| 24-Apr-20 6:13 PM View: | Walbert Timothy P Director | Zyla Life Sciences (ZCOR) | 23-Apr-20 | Option Exercise | 6,667 | $1.75 | $11,667.20 | 100% 0 to 6.67K | |
| 24-Apr-20 6:12 PM View: | Pauls Matthew Director | Zyla Life Sciences (ZCOR) | 23-Apr-20 | Payment of Exercise | 952 | $1.75 | $1,666.00 | (14%) 6.67K to 5.71K | |
| 24-Apr-20 6:11 PM View: | McInnis Joe Director | Zyla Life Sciences (ZCOR) | 23-Apr-20 | Option Exercise | 6,667 | $1.75 | $11,667.20 | 100% 0 to 6.67K | |
| 26-Mar-20 6:23 PM View: | Timmins Megan C. General Counsel | Zyla Life Sciences (ZCOR) | 26-Mar-20 | Option Exercise | 34,334 | $1.60 | $54,934.40 | 100% 0 to 34.33K | |
| 26-Mar-20 6:25 PM View: | Strobeck Mark Chief Operating Officer | Zyla Life Sciences (ZCOR) | 26-Mar-20 | Option Exercise | 62,000 | $1.60 | $99,200.00 | 100% 0 to 62.0K | |
| 26-Mar-20 6:23 PM View: | Timmins Megan C. General Counsel | Zyla Life Sciences (ZCOR) | 26-Mar-20 | Payment of Exercise | 9,435 | $1.60 | $15,096.00 | (27%) 34.33K to 24.9K | |
| 26-Mar-20 6:25 PM View: | Strobeck Mark Chief Operating Officer | Zyla Life Sciences (ZCOR) | 26-Mar-20 | Payment of Exercise | 17,038 | $1.60 | $27,260.80 | (27%) 62.0K to 44.96K | |
| 05-Mar-20 8:43 PM View: | Smiley Andrea Heslin Director | Zyla Life Sciences (ZCOR) | 04-Mar-20 | Grant | 13,620 | -- | -- | 100% 0 to 13.62K | |
| 05-Mar-20 8:41 PM View: | Pauls Matthew Director | Zyla Life Sciences (ZCOR) | 04-Mar-20 | Grant | 13,620 | -- | -- | 100% 0 to 13.62K | |
| 05-Mar-20 8:46 PM View: | Timmins Megan C. General Counsel | Zyla Life Sciences (ZCOR) | 04-Mar-20 | Grant | 58,000 | -- | -- | 100% 0 to 58.0K | |
| 05-Mar-20 8:44 PM View: | Walbert Timothy P Director | Zyla Life Sciences (ZCOR) | 04-Mar-20 | Grant | 13,620 | -- | -- | 100% 0 to 13.62K | |
| 05-Mar-20 8:46 PM View: | Strobeck Mark Chief Operating Officer | Zyla Life Sciences (ZCOR) | 04-Mar-20 | Grant | 79,800 | -- | -- | 100% 0 to 79.8K | |
| 05-Mar-20 8:40 PM View: | Phillips Gary M Director | Zyla Life Sciences (ZCOR) | 04-Mar-20 | Grant | 13,620 | -- | -- | 100% 0 to 13.62K | |
| 05-Mar-20 8:45 PM View: | Smith Todd N President and CEO Director | Zyla Life Sciences (ZCOR) | 04-Mar-20 | Grant | 165,500 | -- | -- | 100% 0 to 165.5K | |
| 05-Mar-20 8:40 PM View: | McInnis Joe Director | Zyla Life Sciences (ZCOR) | 04-Mar-20 | Grant | 13,620 | -- | -- | 100% 0 to 13.62K | |
| 02-Mar-20 8:55 PM View: | Timmins Megan C. General Counsel | Zyla Life Sciences (ZCOR) | 01-Mar-20 | Option Exercise | 40,095 | $1.50 | $60,142.50 | 100% 0 to 40.09K | |
| 02-Mar-20 8:54 PM View: | Strobeck Mark Chief Operating Officer | Zyla Life Sciences (ZCOR) | 01-Mar-20 | Option Exercise | 75,735 | $1.50 | $113,602.00 | 100% 0 to 75.73K | |
| 02-Mar-20 8:55 PM View: | Timmins Megan C. General Counsel | Zyla Life Sciences (ZCOR) | 01-Mar-20 | Payment of Exercise | 10,805 | $1.50 | $16,207.50 | (27%) 40.09K to 29.29K | |
| 02-Mar-20 8:54 PM View: | Strobeck Mark Chief Operating Officer | Zyla Life Sciences (ZCOR) | 01-Mar-20 | Payment of Exercise | 20,812 | $1.50 | $31,218.00 | (27%) 75.73K to 54.92K | |
| 02-Jan-20 7:43 PM View: | Radie Robert S Principal Financial Officer | Zyla Life Sciences (ZCOR) | 31-Dec-19 | Payment of Exercise | 55,085 | $2.50 | $137,712.00 | (42%) 132.0K to 76.92K | |
| 02-Jan-20 7:43 PM View: | Radie Robert S Principal Financial Officer | Zyla Life Sciences (ZCOR) | 31-Dec-19 | Option Exercise | 132,000 | $2.50 | $330,000.00 | 100% 0 to 132.0K | |
| 10-Jan-20 4:21 PM View: | Riva Ridge Capital Manageme... 10% Owner | Zyla Life Sciences (ZCOR) | 30-Dec-19 | Sale | 50,000 | $2.50 | $125,000.00 | (5%) 988.66K to 938.66K | |
| 10-Jan-20 4:21 PM View: | Riva Ridge Capital Manageme... 10% Owner | Zyla Life Sciences (ZCOR) | 23-Dec-19 | Sale | 250,000 | $2.50 | $625,000.00 | (20%) 1.24M to 988.66K | |
| 24-Oct-19 7:44 PM View: | Smith Todd N President and CEO Director | Zyla Life Sciences (ZCOR) | 23-Oct-19 | Grant | 200,000 | -- | -- | 100% 0 to 200.0K | |
| 01-Jul-19 9:13 PM View: | Wilkins H Jeffrey SVP and Chief Medical Officer | Zyla Life Sciences (ZCOR) | 01-Jul-19 | Grant | 190,000 | -- | -- | 100% 0 to 190.0K | |
| 03-Jul-19 5:46 PM View: | Capital Royalty L.P. 10% Owner | Zyla Life Sciences (ZCOR) | 28-Jun-19 | Disposition (other) | 4,586,870 | -- | -- | (50%) 9.17M to 4.59M | |
| 03-Jul-19 5:46 PM View: | Capital Royalty L.P. 10% Owner | Zyla Life Sciences (ZCOR) | 28-Jun-19 | Acquisition (other) | 4,586,870 | -- | -- | 100% 4.59M to 9.17M | |
| 20-Jun-19 4:08 PM View: | Phillips Gary M Director | Zyla Life Sciences (ZCOR) | 18-Jun-19 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 24-Apr-19 8:52 PM View: | Walbert Timothy P Director | Zyla Life Sciences (ZCOR) | 23-Apr-19 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 24-Apr-19 8:53 PM View: | McInnis Joe Director | Zyla Life Sciences (ZCOR) | 23-Apr-19 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 24-Apr-19 8:52 PM View: | Smiley Andrea Heslin Director | Zyla Life Sciences (ZCOR) | 23-Apr-19 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 24-Apr-19 8:53 PM View: | Pauls Matthew Director | Zyla Life Sciences (ZCOR) | 23-Apr-19 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 28-Mar-19 4:02 PM View: | Timmins Megan C. General Counsel | Zyla Life Sciences (ZCOR) | 26-Mar-19 | Grant | 63,000 | -- | -- | 100% 0 to 63.0K | |
| 28-Mar-19 4:01 PM View: | Strobeck Mark Chief Operating Officer | Zyla Life Sciences (ZCOR) | 26-Mar-19 | Grant | 120,000 | -- | -- | 100% 0 to 120.0K | |
| 28-Mar-19 4:01 PM View: | Shea Patrick M Chief Commercial Officer | Zyla Life Sciences (ZCOR) | 26-Mar-19 | Grant | 90,000 | -- | -- | 100% 0 to 90.0K | |
| 28-Mar-19 4:00 PM View: | Radie Robert S President and CEO Director | Zyla Life Sciences (ZCOR) | 26-Mar-19 | Grant | 238,000 | -- | -- | 100% 0 to 238.0K |
